A wealth of evidence documents significant sex differences in the prevalence and prognostic use of traditional risk factors. 1 Studies have shown that global risk scores often categorize women as lower risk than men and even updated risk calculators overestimate clinical outcome burden in women when compared with men. [2] [3] [4] [5] [6] Coupled with the persistently higher case fatality rate for women, these data continue to support markers of subclinical atherosclerosis as offering promise for the improved detection of at-risk women. Coronary artery calcium (CAC) is a subcomponent of atherosclerotic plaque, and its extent, as measured using the Agatston score, provides imaging evidence of the disease burden within the epicardial coronary arteries.
Coronary Calcium Prognosis in Women

Methods
Study Population
From 1996 to 1999, a total of 9715 patients were referred to CAC scanning. All patients did not have a previous coronary artery disease (CAD) diagnosis or symptoms suggestive of CAD. Of this group, a subset analysis of 2363 had a calculated low-intermediate FRS (10- year risk of coronary heart disease, 6%-9.9%). All individuals were clinically referred by their physicians for CAD screening evaluation using CAC scoring. Previous reports from this registry have been published. 11, 12 All individuals provided informed consent for participation in this registry. Deidentified data were sent to Emory University School of Medicine, Weill Cornell Medical College, and Cedars-Sinai Medical Center for analysis; institutional review board approval was garnered for data analysis at each of these institutions. Details of this registry have previously been published. 13, 14 Our subset analysis included asymptomatic women and men with an FRS with expected 10-year risk from 6% to 9.9%. We identified this subset because of the abundant evidence on the effectiveness of risk stratification in those individuals with an intermediate FRS and the data reporting poor discrimination of risk among women. 6, 10 
Cardiac Risk Factor Collection
Baseline traditional risk factors were obtained in the study participants. Categorical risk factor data were collected and include the following: (1) dyslipidemia was considered present for individuals reporting a history of high total cholesterol, high low-density lipoprotein cholesterol, low high-density lipoprotein cholesterol, high triglycerides, or current use of lipid-lowering therapy; (2) hypertension was considered present if one self-reported a history of high blood pressure or the use of antihypertensive medication; (3) cigarette smoking was considered present if the subject was an active smoker at the time of scanning; 4) diabetes mellitus was considered present for those individuals with a baseline use of antidiabetic medication or a history of elevated blood glucose measurement of >126 mg/dL; and (5) family history of premature CAD was present if individuals stated that they had an immediate family member with a history of CAD in a male relative <55 years or a female relative <65 years. An estimated FRS was calculated at the Cedars-Sinai Medical Center by 1 coinvestigator (H.G.) using the coefficients in the report by Wilson et al 1 and as previously reported. 11, 14 
CAC Screening Protocol
Individuals underwent electron beam or multislice computed tomography using standardized procedures as previously detailed. 13, 14 A CAC score was calculated using the methods described by Agatston et al. 15 CAC scores were categorized as 0, 1 to 10, 11 to 99, 100 to 399, and ≥400.
Study Outcome
The primary end point of this study was time to all-cause mortality. Mortality status was conducted by querying the National Death Index. Follow-up status was ascertained through May 2014, and average follow-up for surviving patients was 14.6 (range, 12.9-16.8) years.
Statistical Analysis
We compared women and men by categorical risk factors using a χ 2 statistic. A Mantel-Haenszel test of trend χ 2 statistic was used to compare sex by age decile subsets. Age was compared in women and men using ANOVA techniques. From this analysis, the mean and 95% confidence intervals of age were calculated for women and men. The primary aim of this analysis was time to death from all causes. We estimated time to all-cause mortality using univariable and multivariable Cox proportional hazards models. The Harrell C statistic was calculated for each model. A total of 159 deaths were reported in our cohort, including 86 deaths in women and 73 deaths in men. A stratified Cox survival analysis was used to plot time to all-cause mortality by sex across CAC score strata. Diabetes mellitus was not excluded from this patient subset as it was not a significant predictor of mortality (P=0.07). From the univariable and multivariable models, we calculated the hazard ratios and 95% confidence intervals. A firstorder interaction of sex by CAC scores was calculated. Separate Cox models were also used for women and men, and a separate Cox model was used for patients aged <55 and ≥55 years. Among those aged <55 years, a further stratified analysis was performed among smokers and nonsmokers. Model overfitting procedures were considered, which allowed us to include ≤16 degrees of freedom in the multivariable models. The proportional hazards assumption was met for all Cox models. For each of the models, goodness of fit statistics were not statistically significant. Moreover, we calculated the net reclassification improvement of a model, including cardiac risk factors and the added contribution of CAC to a second model using the methods described by Pencina et al 16 for time to death.
Results
Prevalence of Traditional Risk Factors and CAC in Asymptomatic Women and Men With Low-Intermediate FRS
In our patient subset, low-intermediate risk women were nearly a decade older than their male counterparts (55.6 versus 46.7 years; P<0.0001). In this subset, 14% of women as compared to no men were ≥70 years old. In general, traditional cardiac risk factors were more prevalent in women, including more hypertension, smoking, and a family history of CAD. With Figure 1 . Proportion of asymptomatic women and men classified with a Framingham risk score from 6% to 9.9% based on their age and number of modifiable risk factors (including hypertension, diabetes mellitus, smoking, and dyslipidemia).
exception, men were more likely to be dyslipidemic when compared with women (P=0.005). Younger women and men were more likely to be referred with multiple modifying risk factors ( Figure 1 ; Table 1 ).
Likely the result of an advanced age in women, more extensive CAC was observed in women when compared with men (P=0.029). CAC scores ≥100 occurred in 18.8% of women and 15.1% of men. Figure 2 plots overall 15-year mortality in women versus men. Cumulative mortality was 8.8% for women and 6.0% for men (P<0.0001). Even in adjusted Cox models, women had a 1.44 higher relative hazard for death when compared with men (P=0.022).
Estimating Long-Term 15-Year Mortality in Women Versus Men
Fifteen-Year All-Cause Mortality Rates by CAC Scores in Women and Men
For women, CAC scores had 15-year mortality ranging from 5.0% for CAC score of 0 to 23.5% for a CAC score ≥400 (Figure 3 ; P<0.001). For men, CAC scores had 15-year mortality ranging from 3.5% for CAC score of 0 to 18.0% for a CAC score ≥400 (P<0.001).
Multivariable Risk Models in Women and Men
In separate models, CAC was a significant correlate of longterm mortality in women and men. In risk factor-adjusted models, the relative hazard for death ranged from 1.9 to 6.5 for women with CAC scores from 1 to 10 to ≥400 (P<0.0001). Among women, based on a stepwise Cox model, CAC scores were the single greatest correlate of long-term mortality followed by age, hypertension, and smoking. By comparison, for men, the hazard ratios were 1.7, 2.9, 4.1, and 2.7, respectively, for CAC scores of 1 to 10, 11 to 99, 100 to 399, and ≥400 (P<0.0001). Among men, based on a stepwise Cox model, CAC scores were the single greatest correlate of long-term mortality followed by smoking ( Table 2) . The Harrell C statistic for the individual models for risk factors alone and for models, including risk factors with the CAC scores, is reported in Table 3 for women and men. The models containing risk factors plus CAC scores have a higher Harrell C statistic for women and men.
Net Reclassification Improvement Statistics
The net reclassification improvement for women was 0.155 (P=0.002) and 0.094 for men (P=0.03). Of the female survivors, 93 and 33 women were correctly and incorrectly reclassified to a lower risk patient subset based on CAC findings, with a total of 6.2% correct reclassification of low-risk women. This may be compared with only 3.9% of men correctly reclassified as low risk based on CAC findings. There was a similar pattern of a higher percent correct reclassification of high-risk women when compared with men although the numbers (in general) were small ( Figure 4A and 4B ).
Discussion
Considerable focus has been placed on the evaluation of sexspecific differences in case fatality rates and in the overall burden of cardiovascular disease among women and men. 17, 18 Data have been conflicting as to whether women are at an elevated risk or whether they are at lower risk when compared with their male counterparts. In many cases, age and other comorbidities accentuate sex-specific risk differences. 17, 18 Yet, for most of the global risk scores, the ability to precisely and reliably categorize risk in women has often been suboptimal when compared with men. 5 Even for the updated risk calculators, the ability to estimate risk in women is far from optimal. In 1 recent report from the Women's Health Study, the predicted event rates from the risk calculator overestimated event rates by 1.4-to 1.9-fold when compared with the observed event data. 6 It seems that integration of global risk based on risk factors is consistently subpar for women when compared with men. 10 This finding that risk calculators perform poorly in women is problematic as they form the basis for guideline-directed preventive treatment. Moreover, although medical treatment is recommended for higher risk patients, there remains a sizeable proportion of the population with borderline risk scores at an elevated but not intermediate risk who may benefit from guided lifestyle changes to improve their long-term outlook. The lack of precision of risk calculators in women and the importance of lifestyle alterations in improving risk factor control remain an important goal for at-risk patients with an FRS or other global score insufficient to warrant medical management. Accordingly, our evaluation of the effectiveness of risk stratification in women with a low-intermediate FRS has relevance to guide the selection of those likely to benefit from exercise and dietary recommendations toward improved risk factor control. Our results revealed that CAC was highly effective at risk stratifying this subset of women. In particular, among women aged ≥55 years, CAC scores >10 were associated with a higher relative hazard for death when compared with men. These data were surprising, but they may reflect the under appreciation of global risk for these older women. Moreover, it may also be noted that our lengthy follow-up may have unearthed findings that would not have been reported for shorter term (more typical) follow-up of 3 to 5 years. 13, 19 
Long-Term Outcomes and Older-Aged Women
Importantly, our women were nearly a decade older than their male counterparts despite having a similar low-intermediate FRS. This older age certainly would precipitate the greater mortality risk and association with CAC scores in women when compared with men. But it remains important to note that in population cohorts, global risk scores calculate as many as ≥90% of women to lower risk categories. 20 Thus, if global risk scores are the foundation of preventive care, then caveats of age and the burden of subclinical atherosclerosis should play a prominent role in understanding (particularly) long-term risk among women and men. We think that our longer duration of follow-up of 15 years approximates previous reports that have provided lifetime risk estimates. [21] [22] [23] 
Previous Reports on Prognosis by CAC Among Women
Among our cohort of low-intermediate FRS women, CAC scores had 15-year mortality rates ranging from 5.0% for CAC score of 0 to 23.5% for a CAC score ≥400 (P<0.001). By comparison, for men, 15-year mortality rates ranged from 3.5% to 18.0% for CAC scores from 0 to ≥400 (P<0.001). Interestingly, various CAC scores had a higher mortality risk in women when compared with men. The relative hazards for deaths ranged from 2-to 6-fold higher for women when compared with men with CAC scores >10 to ≥400. Previous reports from our investigative group have examined the prognostic use of CAC among women over shorter durations of follow-up (≈5 years). 24, 25 In general, some exploratory findings report an elevated mortality risk among women with higher risk CAC scores. 26 However, from a meta-analysis of 3 studies, including 6,481 women and 13,697 men, a comparative analysis revealed no statistical differences by sex across mild-to highrisk CAC scores (P=0.66). 26 Our findings reveal that women who are of less than intermediate risk (and not candidates for CAC screening based on current clinical practice guidelines) have a higher long-term mortality risk. Importantly, CAC findings significantly elevated the relative hazard for 15-year mortality in women when compared with men. These findings from our single-center registry support that women at risk who may benefit from CAC screening include women with a lowintermediate FRS.
No randomized trial evidence is available to precisely define treatment options for this lower risk group of women. But we think that the benefit of CAC screening in this lower risk cohort is not for discerning guideline-directed statin therapy but in focusing clinical care toward lifestyle modification and improved adherence to risk factor modifying therapy.
Registry Limitations
We have provided details of registry limitations in previous reports. 11, 12 This report includes data collection and follow-up from a single center with generalizability limited to outpatient centers with similar referral patterns. Our report details a significantly longer duration of follow-up then previous CAC prognostic studies; yet, death from all causes was the lone, primary end point for this registry. 10 Data from other cardiovascular events may have altered our presented findings. Death misclassification is common when cardiovascular causality is determined and is not of concern when evaluating death from all causes. 27 Also, the categorical risk factor data set did not include information on blood pressure and glucose, which may have resulted in an overestimation in the value of CAC scoring. The FRS was calculated based on β coefficients in the report by Wilson et al. 1 A new risk calculator has been published to improve detection of minority population subsets, notably black individuals, although validation cohorts have not elicited marked improvement in outcome discrimination for women when compared with previous series applying the FRS. 6,28
Conclusions
The primary findings in this report are that CAC may effectively risk stratify women who are slightly lower risk than those conventionally targeted to undergo imaging for screening, including those with an intermediate FRS. Our cohort represents an at-risk group below the current threshold targeted for statin therapy but whose risk assessment findings represent an opportunity to guide the intensity of lifestyle recommendations. Moreover, given the reduced capacity of global risk scores to accurately and reliably classify risk in women, our findings provide information on an at-risk but with largely an insufficient risk factor burden to warrant statin therapy based on current guidelines. 29, 30 However, our findings are important as they focus on an at-risk cohort, particularly women, whose risk may be under appreciated and further guided by screening with CAC. The long-term follow-up of our cohort provides a unique perspective on the use of CAC in women and men with a low-intermediate FRS. Women have a greater prevalence of CAC, an elevated mortality, and an increased relative hazard for 15-year death when compared with their male counterparts. These findings of an elevated mortality for women when compared with men with a CAC score >10 were noteworthy and add to the evidence that CAC is a valuable adjunct for selected screening of patient cohorts where global risk scores may fall short of optimal detection of risk among women.
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